Edition:
United States

Globus Medical Inc (GMED.N)

GMED.N on New York Stock Exchange

48.48USD
22 Feb 2018
Change (% chg)

$0.48 (+1.00%)
Prev Close
$48.00
Open
$50.25
Day's High
$50.82
Day's Low
$48.23
Volume
203,942
Avg. Vol
175,717
52-wk High
$50.82
52-wk Low
$26.95

Chart for

About

Globus Medical, Inc. is a medical device company. The Company is focused on developing products for patients with musculoskeletal disorders. It is focused on products to treat patients with spine disorders. The Company's products fall under categories, which include Innovative Fusion and Disruptive Technologies. The Innovative... (more)

Overall

Beta: 0.43
Market Cap(Mil.): $4,626.05
Shares Outstanding(Mil.): 96.38
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 50.18 16.52
EPS (TTM): -- -- --
ROI: -- 14.12 36.19
ROE: -- 16.71 17.38

BRIEF-Globus Medical Q4 Earnings Per Share $0.25

* GLOBUS MEDICAL REPORTS FULL YEAR AND FOURTH QUARTER 2017 RESULTS

Feb 21 2018

BRIEF-Globus Medical Expects Q4 Sales Of About $175.5 mln

* GLOBUS MEDICAL REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR SALES RESULTS

Jan 09 2018

BRIEF-Globus Medical sees Q4 2017 sales about $175.5 million

* GLOBUS MEDICAL REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR SALES RESULTS

Jan 09 2018

BRIEF-Globus Medical reports Q3 earnings per share $0.26

* Q3 earnings per share view $0.30 -- Thomson Reuters I/B/E/S

Nov 08 2017

BRIEF-Globus Medical ‍expects first revenues from sale of ExcelsiusGPS systems in Q4 2017

* Globus Medical announces first spine surgeries using ExcelsiusGPS

Oct 10 2017

BRIEF-Globus Medical appoints David Demski as CEO

* Globus Medical Inc - ‍Paul will remain in role of executive chairman​

Aug 29 2017

Earnings vs. Estimates